Summit Global Investments Takes Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Summit Global Investments purchased a new position in shares of Phibro Animal Health Co. (NASDAQ:PAHC) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 27,181 shares of the company’s stock, valued at approximately $571,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of PAHC. Quantbot Technologies LP acquired a new stake in shares of Phibro Animal Health during the third quarter worth about $70,000. New York State Teachers Retirement System boosted its position in shares of Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after purchasing an additional 775 shares during the period. Amundi boosted its position in shares of Phibro Animal Health by 185.5% in the 4th quarter. Amundi now owns 9,855 shares of the company’s stock valued at $212,000 after purchasing an additional 6,403 shares during the period. Zacks Investment Management acquired a new stake in shares of Phibro Animal Health in the 3rd quarter valued at about $274,000. Finally, SG Americas Securities LLC boosted its position in shares of Phibro Animal Health by 7.4% in the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock valued at $276,000 after purchasing an additional 906 shares during the period. 99.34% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on PAHC shares. StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Saturday, March 15th. Morgan Stanley raised their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Finally, Barclays raised their price target on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $21.00.

Phibro Animal Health Stock Performance

NASDAQ:PAHC opened at $21.90 on Monday. The firm has a market cap of $887.02 million, a price-to-earnings ratio of 45.63, a price-to-earnings-growth ratio of 0.45 and a beta of 0.58. The firm’s fifty day moving average price is $22.68 and its 200 day moving average price is $22.63. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. Phibro Animal Health Co. has a 1-year low of $12.14 and a 1-year high of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, sell-side analysts expect that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.19%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 100.00%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.